Taboco, Naome .
HRN: 23-03-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/17/2023
CEFUROXIME 1.5GM (VIAL)
11/18/2023
11/19/2023
IV
1.5 Grams
PTOR
For TAHBSO
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes